Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02034110
Title	Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	GlaxoSmithKline
Indications	thyroid cancer gastrointestinal stromal tumor biliary tract cancer germ cell cancer multiple myeloma high grade glioma hairy cell leukemia small intestine adenocarcinoma
Therapies	Dabrafenib + Trametinib
Age Groups:	adult
Covered Countries	USA \| SWE \| NOR \| NLD \| ITA \| FRA \| ESP \| DNK \| DEU \| CAN \| BEL \| AUT